- GPCR Antibodies
- Generation of monoclonal antibodies that recognize native GPCR conformations as therapeutics, for target validation, and for GPCR crystallography.
- Crystal structures of GPCRs for in silico screening and lead optimization.
Cryo-EM structures of GPCRs for in silico screening and lead optimization.
- Computational Structure-based Drug Discovery
Computational structure-based drug discovery on both active-state and inactive state crystal or cryo-EM structures using our in-house clusters and structures.